Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
General Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
M.B.B.S, MS
Rheumatologist
M.B.B.S., F.C.P.S. (General Medicine), F.C.P.S. (Rheumatology)
Family Physician
M.B.B.S., Postgraduate Diploma in Endocrinology
Gastroenterologist
MBBS, FCPS (Gastroenterology), FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS Medicine
Cardiologist
M.B.B.S., MMSc (Cardiology), Dip Echo, MRCP (UK), Cert. in Diabetes
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Diabetologist
MBBS, Post Graduate Diploma In Diabetes (DIP)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures